MyMyelomaTeam

CAR-T cell therapy has shown promising results in extending the life expectancy of multiple myeloma patients. According to the knowledge base:

- New breakthroughs have extended survival out 10 to 15 years in some patients
- In a study, 14 out of 19 patients reached the highest level of remission with no relapses, Show Full Answer

CAR-T cell therapy has shown promising results in extending the life expectancy of multiple myeloma patients. According to the knowledge base:

- New breakthroughs have extended survival out 10 to 15 years in some patients.
- In a study, 14 out of 19 patients reached the highest level of remission with no relapses, including five patients followed for more than a year.

However, individual outcomes can vary, and it's essential to discuss specific prognosis with a healthcare provider.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Understanding Life Expectancy With Relapsed/Refractory Myeloma | MyMyelomaTeam